The company's gene-editing-focused platform looks promising.

Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and ...

A peer-reviewed study of 230 human clinical samples found that a CRISPR-assisted nanodroplet assay identified NTM species and ...

The Partita CRISPR activation library identified Irx5 as a gene linked to venetoclax resistance and Runx2, Runx3 and Csf1r as ...

Billionaire investor Cathie Wood, through her ARK ETFs, made big buys of CRISPR Therapeutics on Friday, Oct. 9, and Monday, ...

Human cells hold about two meters (6.6 feet) of DNA, folded and compacted to fit inside a nucleus. That packing is essential ...

Late last month, Anthropic claimed it had discovered a curious stretch of DNA in a virus called a bacteriophage that repeats ...

Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.

Experts at the company don't know what the newfound system does, so its potential utility in biology—if any—remains unclear. But the work marks a major advancement because the A.I. made this discovery ...

An AI model spotted a strange pattern in a virus's DNA that looks a little like CRISPR. Its makers cannot yet say what it ...

Banas is associate director of research at the Gene Editing Institute at ChristianaCare, where Kmiec is founder and executive director. The medical promise of CRISPR gene editing can be seen most ...

Raju has been a trusted partner to me and a wonderful colleague during his time at CRISPR Therapeutics," said Samarth ...